Developing a yeast system to study virus-host interactions in Mononegavirales

开发酵母系统来研究单链病毒目中病毒与宿主的相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): The major objective of this application is to develop and optimize a unique yeast system for systematic identification and characterization of host factors of viral genome replication and gene expression in nonsegmented negative-strand (NNS) RNA viruses (taxonomic order Mononegavirales). This order contains a wide variety of human and animal viruses, including many lethal human pathogens. The viral RNA polymerase of NNS RNA viruses consists of two viral subunits, and includes a number of largely unidentified host protein factors. Our current understanding of the contributions of host proteins in viral replication is very limited, and there is an urgent need to develop new systematic approaches to the identification of host factors, which should serve as promising antiviral targets. The proposed pilot experiments will be focused on a prototypic Mononegavirales, vesicular stomatitis virus (VSV, a rhabdovirus). The first aim will test the feasibility of the yeast Saccharomyces cerevisiae as an experimental host supporting genome replication and gene expression of VSV. If it works, this system should be suitable for efficient, cost-effective, and high-throughput systematic identification of host protein factors important for viral RNA synthesis in VSV and other Mononegavirales. The second aim will employ a newly-developed "cytoplasmic" yeast 2-hybrid system for the identification of cellular proteins physically interacting with VSV proteins. The identification of host factors of virus RNA replication and transcription should provide new clues for understanding the molecular mechanisms of viral RNA synthesis and for developing new ways to combat viral infections via control of host components. PUBLIC HEALTH RELEVANCE: The major objective of this application is to develop a new yeast-based experimental system to study virus- host interactions in nonsegmented negative-strand RNA viruses (taxonomic order Mononegavirales). This order contains many lethal human pathogens, including the Ebola and Marburg viruses which are classified as category A bioweapon agents by the Centers for Disease Control and Prevention, and highly prevalent human pathogens, such as the respiratory syncytial and parainfluenza viruses. Although infections caused by many Mononegavirales have been largely controlled in the developed world through a variety of vaccination and therapeutic strategies, they still cause many clinically devastating diseases (including many emerging diseases), which contribute significantly to world-wide morbidity and mortality. It continues to be important to define the basic mechanisms of reproduction of these viruses, especially virus-host interactions, with the ultimate hope that this knowledge will contribute not only to the basic understanding of virus biology, but will also lead to new or better therapeutic agents.
描述(由申请人提供):本申请的主要目的是开发和优化一种独特的酵母系统,用于系统鉴定和表征非节段负链(NNS)RNA病毒(分类学目的为单负链病毒目)中病毒基因组复制和基因表达的宿主因子。该目包含多种人类和动物病毒,包括许多致命的人类病原体。NNS RNA病毒的病毒RNA聚合酶由两个病毒亚基组成,并且包括许多基本上未鉴定的宿主蛋白因子。我们目前对宿主蛋白在病毒复制中的贡献的理解非常有限,迫切需要开发新的系统方法来鉴定宿主因子,这些因子应作为有前途的抗病毒靶点。拟议的试点实验将集中在一个原型单负性病毒目,水泡性口炎病毒(VSV,弹状病毒)。第一个目标是测试酿酒酵母作为支持VSV基因组复制和基因表达的实验宿主的可行性。如果它的工作,该系统应该是适合于有效的,成本效益高,高通量的系统鉴定宿主蛋白质的重要因素的病毒RNA合成VSV和其他单负性病毒。第二个目标将采用新开发的“细胞质”酵母双杂交系统,用于鉴定与VSV蛋白质物理相互作用的细胞蛋白质。病毒RNA复制和转录的宿主因子的鉴定将为理解病毒RNA合成的分子机制和开发通过控制宿主成分来对抗病毒感染的新方法提供新的线索。公共卫生相关性:本申请的主要目的是开发一种新的基于酵母的实验系统,以研究非节段负链RNA病毒(分类目的单负链RNA病毒目)中的病毒-宿主相互作用。该目包含许多致命的人类病原体,包括埃博拉病毒和马尔堡病毒,它们被疾病控制和预防中心归类为A类生物武器制剂,以及高度流行的人类病原体,如呼吸道合胞病毒和副流感病毒。尽管在发达国家,通过各种疫苗接种和治疗策略,由许多单负性病毒目引起的感染已在很大程度上得到控制,但它们仍然引起许多临床破坏性疾病(包括许多新兴疾病),这显著地导致了世界范围的发病率和死亡率。确定这些病毒繁殖的基本机制,特别是病毒与宿主的相互作用仍然很重要,最终希望这些知识不仅有助于对病毒生物学的基本理解,而且还将导致新的或更好的治疗药物。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach.
  • DOI:
    10.1186/1743-422x-6-166
  • 发表时间:
    2009-10-12
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Moerdyk-Schauwecker M;Hwang SI;Grdzelishvili VZ
  • 通讯作者:
    Grdzelishvili VZ
Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin.
  • DOI:
    10.1371/journal.pone.0011265
  • 发表时间:
    2010-06-22
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Shah NR;Sunderland A;Grdzelishvili VZ
  • 通讯作者:
    Grdzelishvili VZ
Detecting protein-protein interactions in vesicular stomatitis virus using a cytoplasmic yeast two hybrid system.
  • DOI:
    10.1016/j.jviromet.2011.02.006
  • 发表时间:
    2011-05
  • 期刊:
  • 影响因子:
    3.1
  • 作者:
    Moerdyk-Schauwecker, Megan;DeStephanis, Darla;Hastie, Eric;Grdzelishvili, Valery Z.
  • 通讯作者:
    Grdzelishvili, Valery Z.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Valery Zurabovich Grdzelishvili其他文献

Valery Zurabovich Grdzelishvili的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Valery Zurabovich Grdzelishvili', 18)}}的其他基金

CELLULAR PATHWAYS AFFECTING ONCOLYTIC VIRUS-HOST INTERACTIONS IN CANCER
影响癌症中溶瘤病毒与宿主相互作用的细胞途径
  • 批准号:
    9099084
  • 财政年份:
    2016
  • 资助金额:
    $ 7.2万
  • 项目类别:
MUC1 AND RESISTANCE OF CANCER CELLS TO ONCOLYTIC VIROTHERAPY
MUC1 和癌细胞对溶瘤病毒疗法的抵抗
  • 批准号:
    8290645
  • 财政年份:
    2012
  • 资助金额:
    $ 7.2万
  • 项目类别:
Role of RIG-like receptors in virally induced CNS inflammation
RIG样受体在病毒诱导的中枢神经系统炎症中的作用
  • 批准号:
    8021833
  • 财政年份:
    2010
  • 资助金额:
    $ 7.2万
  • 项目类别:
Role of RIG-like receptors in virally induced CNS inflammation
RIG样受体在病毒诱导的中枢神经系统炎症中的作用
  • 批准号:
    7895316
  • 财政年份:
    2010
  • 资助金额:
    $ 7.2万
  • 项目类别:
L polymerase domains and mRNA posttranscriptional modifications in Mononegavirale
Mononegavirale 中的 L 聚合酶结构域和 mRNA 转录后修饰
  • 批准号:
    7457099
  • 财政年份:
    2008
  • 资助金额:
    $ 7.2万
  • 项目类别:
Developing a yeast system to study virus-host interactions in Mononegavirales
开发酵母系统来研究单链病毒目中病毒与宿主的相互作用
  • 批准号:
    7449892
  • 财政年份:
    2008
  • 资助金额:
    $ 7.2万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 7.2万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 7.2万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 7.2万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 7.2万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了